Meet BrosMed at ML CTO Endovascular Course 2024
Release time:
2024-04-23
BrosMed Medical is delighted to attend the upcoming 3rd edition MULTI-LEVEL CTO Endovascular Course from May 2nd to 3rd this year in beautiful Brussels, Belgium.
BrosMed Medical is delighted to attend the upcoming 3rd edition MULTI-LEVEL CTO Endovascular Course from May 2nd to 3rd this year in beautiful Brussels, Belgium.
Be sure to visit our booth to learn more about our product offerings and gain new insights into BrosMed launched Complex PAD & AVF Solutions:
Tri-Wedge™ PTA Scoring Balloon Dilatation Catheter: Three Triangular metallic wires 360° for precise & effective dilatation
Tiche™ High Pressure PTA Balloon Dilatation Catheter: Deliverable high pressure with a low tip entry profile 0.040”
We sincerely looking forward to meet you there and get inspiration from each other!
ABOUT BROSMED MEDICAL
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers(Labs), 2 manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 20 product series and 400+ products registration certificates in worldwide.
ABOUT Multi-Level CTO Endovascular Course
Multi-Level CTO Endovascular Course is conceived to bring together a multidisciplinary group of vascular specialists from Europe and Middle East to engage in the highest standard educational format with a spirit of collegiality and inclusion.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
Webinar Invitation | Innovations and Novel Strategies in CHIP PCI
Mark your calendar: Wednesday, March 26 🕒 18:00-19:30 (Beijing Time) | 11:00-12:30 (CET)
2025-03-19
On February 10, BrosMed and Cordis signed an agreement for the exclusive distribution of VaSecure™, BrosMed’s next-generation drug-coated peripheral balloon catheter in the China market.
2025-02-12
BrosMed Medical Obtains CE Mark for RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical is excited to announce that it has obtained CE mark for the RevoEdge High-Pressure Coronary Cutting Balloon under the European Medical Device Regulation (MDR). Redefining the standards of cutting balloons, this cutting-edge device is designed to offer unparalleled cutting performance and crossability.
2025-01-07
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26